EMD-36788

Single-particle
3.68 Å
EMD-36788
3D View Gallery
Deposition: 10/07/2023
Map released: 09/10/2024
Last modified: 22/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-36788
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8k18 summary report (pdf.gz) Map and 8k18 FULL report (pdf.gz)
EMICSS annotations (xml)

Neutralization antibody ZCP4C9 bound with SARS-CoV-2 Omicron BA.5 RBD

EMD-36788

Single-particle
3.68 Å
EMD-36788
3D View Gallery
Deposition: 10/07/2023
Map released: 09/10/2024
Last modified: 22/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: Neutralization antibody ZCP4C9 bound with SARS-CoV-2 Omicron BA.5 RBD
Fitted models: 8k18

Deposition Authors: Tang B, Dang S
Ultrapotent class I neutralizing antibodies post Omicron breakthrough infection overcome broad SARS-CoV-2 escape variants.
Luo M, Zhou R, Tang B, Liu H, Chen B, Liu N, Mo Y, Zhang P, Lee YL, Ip JD, Wing-Ho Chu A, Chan WM, Man HO, Chen Y, To KK, Yuen KY, Dang S, Chen Z
(2024) Ebiomedicine , 108 , 105354 - 105354
PUBMED: 39341153
DOI: doi:10.1016/j.ebiom.2024.105354
ISSN: 2352-3964